Early airway infection, inflammation, and lung function in cystic fibrosis

G M Nixon1, D S Armstrong, R Carzino

  • 1Department of Respiratory Medicine, Royal Children's Hospital, Melbourne, Australia. gillian.nixon@muhc.mcgill.ca

Insights

In young children with cystic fibrosis (CF), both respiratory symptoms and lower airway infections independently worsen lung function. Airway inflammation did not show a direct link to lung function decline in this study.

Area of Science:

  • Pediatric Pulmonology
  • Cystic Fibrosis Research
  • Respiratory Medicine

Background:

  • Cystic Fibrosis (CF) affects multiple organs, particularly the lungs.
  • Early detection and monitoring of lung health in infants and young children with CF are crucial.
  • Understanding factors influencing lung function in early CF is essential for timely intervention.

Purpose of the Study:

  • To investigate the relationship between lower airway infection, inflammation, and respiratory symptoms with lung function in young children with CF.
  • To assess the impact of infection and inflammation on lung function parameters.
  • To determine if respiratory symptoms correlate with objective measures of infection or inflammation.

Main Methods:

  • Prospective study of children under 3 years old with CF diagnosed via newborn screening.
  • Bronchial lavage (BL) for infection and inflammation markers (neutrophils, IL-8, elastase) and lung function testing (FEV) under general anesthesia.
  • Correlation analysis between infection, inflammation markers, respiratory symptoms (cough), and lung function (FEV0.5, FEV0.75, FEV1).

Main Results:

  • Lower airway infection was associated with a 10% reduction in FEV(0.5) in children with CF.
  • No significant correlation was found between airway inflammation markers and lung function.
  • Daily cough was linked to lower lung function, independent of infection or inflammation status.

Conclusions:

  • Respiratory symptoms and lower airway infections independently and additively impact lung function in young children with CF.
  • Airway inflammation does not appear to be a primary driver of lung function decline in this age group.
  • Further research is required to elucidate the mechanisms of airway obstruction in early-stage CF.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...